Changes of intestinal microflora of breast cancer in premenopausal women

• Published in: European journal of clinical microbiology & infectious diseases Vol. 40; no. 3; pp. 503 - 513
• Main Authors: He, Chuan, Liu, Yue, Ye, Shandong, Yin, Shiwu, Gu, Junfei
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-03-2021; Springer Nature B.V
• Subjects: Bacteria; Biomedical and Life Sciences; Biomedicine; Breast cancer; Cell culture; Cell viability; Desulfovibrio; Diagnosis; Fatty acids; Flora; Gene sequencing; Internal Medicine; Intestinal microflora; Intestine; Medical Microbiology; Menopause; Metabolites; Metabolomics; Original Article; Pediococcus; Propionic acid; rRNA 16S; Symbiosis; Tumor cell lines; Tumors; Short-chain fatty acid; Breast cancer; Intestinal flora; Premenopausal women
• ISSN: 0934-9723; 1435-4373
• DOI: 10.1007/s10096-020-04036-x

Breast cancer is one of the most common malignant tumors in women. More than half of breast cancer patients are not menopausal at the time of diagnosis. The occurrence and development of premenopausal breast cancer are affected by many factors. Intestinal flora, especially SCFA-producing bacteria, participates in the development of various tumors, and there is a lack of in-depth research in premenopausal breast cancer patients. We used 16S rRNA gene sequencing, targeted metabolomics, and cell culture methods to analyze the changes in the intestinal flora and metabolites of premenopausal breast cancer patients. In addition, we treated breast cancer cells with significantly altered propionate and butyrate in vitro to examine their effects on cell activity. This study followed STROBE guidelines. We found that compared with healthy premenopausal women, the composition and symbiosis of intestinal flora in patients with premenopausal breast cancer changed significantly. The abundance of short-chain fatty acid (SCFA)–producing bacteria was significantly reduced, and the key SCFA-producing enzymes were also significantly reduced.
Pediococcus
and
Desulfovibrio
could distinguish premenopausal breast cancer patients from normal premenopausal women. The related propionate and butyrate had a certain ability to inhibit breast cancer cell viability in vitro. As SCFA-producing bacteria, Pediococcus and Desulfovibrio showed potential reference value for the diagnosis of premenopausal breast cancer. The ability of propionate and butyrate to inhibit breast cancer cell lines in vitro suggests that the relevant SCFA receptor may be a new target for the treatment of premenopausal breast cancer.